1. Home
  2. ITOS vs RGP Comparison

ITOS vs RGP Comparison

Compare ITOS & RGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITOS
  • RGP
  • Stock Information
  • Founded
  • ITOS 2011
  • RGP 1996
  • Country
  • ITOS United States
  • RGP United States
  • Employees
  • ITOS N/A
  • RGP N/A
  • Industry
  • ITOS Biotechnology: Biological Products (No Diagnostic Substances)
  • RGP Business Services
  • Sector
  • ITOS Health Care
  • RGP Consumer Discretionary
  • Exchange
  • ITOS Nasdaq
  • RGP Nasdaq
  • Market Cap
  • ITOS 323.2M
  • RGP 266.4M
  • IPO Year
  • ITOS 2020
  • RGP 2006
  • Fundamental
  • Price
  • ITOS $9.17
  • RGP $8.88
  • Analyst Decision
  • ITOS Strong Buy
  • RGP Hold
  • Analyst Count
  • ITOS 4
  • RGP 3
  • Target Price
  • ITOS $32.50
  • RGP $13.00
  • AVG Volume (30 Days)
  • ITOS 692.7K
  • RGP 305.8K
  • Earning Date
  • ITOS 11-15-2024
  • RGP 01-02-2025
  • Dividend Yield
  • ITOS N/A
  • RGP 6.32%
  • EPS Growth
  • ITOS N/A
  • RGP N/A
  • EPS
  • ITOS N/A
  • RGP 0.36
  • Revenue
  • ITOS $35,000,000.00
  • RGP $599,567,000.00
  • Revenue This Year
  • ITOS $271.18
  • RGP N/A
  • Revenue Next Year
  • ITOS N/A
  • RGP $14.18
  • P/E Ratio
  • ITOS N/A
  • RGP $24.36
  • Revenue Growth
  • ITOS N/A
  • RGP N/A
  • 52 Week Low
  • ITOS $8.41
  • RGP $7.90
  • 52 Week High
  • ITOS $18.75
  • RGP $14.63
  • Technical
  • Relative Strength Index (RSI)
  • ITOS 46.37
  • RGP 57.97
  • Support Level
  • ITOS $8.41
  • RGP $7.90
  • Resistance Level
  • ITOS $9.14
  • RGP $8.45
  • Average True Range (ATR)
  • ITOS 0.49
  • RGP 0.23
  • MACD
  • ITOS 0.21
  • RGP 0.12
  • Stochastic Oscillator
  • ITOS 71.58
  • RGP 85.96

About ITOS iTeos Therapeutics Inc.

ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.

About RGP Resources Connection Inc.

Resources Connection Inc provides consulting and business initiative support services predominantly through its operative subsidiary, Resources Global Professionals. It has two segments RGP ( Resources Global Professionals.) and Sitrick. The RGP segment is focused on delivering consulting services catering to its client's operational needs and change initiatives utilizing a combination of bench and on-demand, talent. The Sitrick segment provides corporate, financial, transactional, and crisis communication and management services. The company generates a majority of its revenue from the RGP segment. Geographically, it derives its key revenue from North America and the rest from Europe and the Asia Pacific region.

Share on Social Networks: